FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for tretinoin submitted by Padagis US LLC, authorizing changes to the product's labeling under ANDA075213.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris
• Acute Promyelocytic Leukemia

Drugs mentioned

• TRETINOIN (TRETINOIN)

Snippet

SUPPL AP for TRETINOIN (TRETINOIN)